NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, ...
The Supreme Court is returning on Monday to begin the 2023-2024 term, which will include key cases on gun rights and free ...
The justices will address freedom of expression, the abortion pill, the right to bear arms and the powers of public agencies, ...
The Supreme Court is scheduled to decide several key cases in its 2023-24 term, which starts Monday.Nearly three dozen appeals are on the argument docket. Several dozen more are expected to be added ...
On the edge of downtown Worcester, between a church and a busy transit station, dozens of people stood waiting in a soft ...
In mid-September, the Food and Drug Administration (FDA) approved boosters made by Pfizer-BioNTech and Moderna to target such ...
Karuna Therapeutics’ CEO Bill Meury said: “KarXT, if approved, will represent the first novel pharmacological approach to treating schizophrenia in several decades and provide a new treatment option ...
to be approved as a third-line therapy in adult patients with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL). The regulatory journey for odronextamab ...
